CytomX Therapeutics, Inc. (CTMX) market cap

Market cap today
$422.93M

CytomX Therapeutics, Inc. (CTMX) has a market cap of $422.93M. At the end of fiscal 2025 (December 31, 2025) its market cap was $587.61M. That is 573.2% higher than the $87.29M of fiscal 2024. Today's figure is 28.0% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 06:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$422.93M
Market cap, fiscal 2025
$587.61M
Change on fiscal 2024
+573.2%
Growth, 5 years
+14.2% a year
Highest on record
$587.61Mfiscal 2025
Lowest on record
$87.29Mfiscal 2024
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

CytomX Therapeutics, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 14.2% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $587.61M in fiscal 2025 and the lowest $87.29M in fiscal 2024.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

CytomX Therapeutics, Inc. market cap, year by year

CytomX Therapeutics, Inc. (CTMX) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$422.93M—$1.94—
2025$587.61M 573.2% up$4.26137.94M
2024$87.29M 23.7% down$1.0384.75M
2023$114.40M 8.8% up$1.5573.81M
2022$105.18M 62.1% down$1.6065.74M
2021$277.76M 8.1% down$4.3364.15M
2020$302.25M 19.8% down$6.5546.15M
2019$376.74M—$8.3145.34M
2018——$15.10—
2017——$21.11—
2016——$10.99—
2015——$20.87—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on CTMX

CytomX Therapeutics, Inc., figure by figure

CytomX Therapeutics, Inc. (CTMX) overview: price, valuation and scorecard

CytomX Therapeutics, Inc. market cap: questions and answers

What is CytomX Therapeutics, Inc.'s market cap?

CytomX Therapeutics, Inc. (CTMX) has a market cap of $422.93M. At the end of fiscal 2025 (December 31, 2025) its market cap was $587.61M. That is 573.2% higher than the $87.29M of fiscal 2024.

What is the growth rate of CytomX Therapeutics, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 14.2% a year.

What are the highest and lowest market cap figures on record for CytomX Therapeutics, Inc.?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $587.61M in fiscal 2025 and the lowest $87.29M in fiscal 2024.

How is CytomX Therapeutics, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CytomX Therapeutics, Inc. (CTMX) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/CTMX/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.